BioTissue SA

BioTissue SA, public limited company in Genève (GE), wholesale. Registration active in the commercial register since 2017. Latest publication: July 13, 2022. UID CHE-110.088.936.

BioTissue Technologies SA provides information about chondrotissue® and the BioSeed®-Cell therapy technology platform. The company invites patients and medical professionals to contact it for more information.¹

Commercial register

Legal form: Public limited company
Registered office: Rue Paul-Bouchet 5, 1201 Genève
Share capital: CHF 2,130,414
UID: CHE-110.088.936
Registered since: 2017
Registered purpose (original language): de distribuer des produits biomédicaux (cf. statuts pour but complet).

Prospex data

Sector: Wholesale trade¹
Website: With an account
Officers: With an account
Headcount: With an account
Signals: Capital increase July 19, 2021 See moreShow less
A free account opens every signal for BioTissue SA, the last 90 days included. Create a free account

An account opens each locked row: the website, the officers, the headcount and every signal for BioTissue SA, the last 90 days included.

Create a free account

Free account, no card.

All 5 companies registered at this address

Similar companies

BioTissue Technologies SA Genève Manufacture of basic pharmaceutical products
Volumina Medical SA Epalinges Other manufacturing
Regenosca SA Lausanne Manufacture of basic pharmaceutical products
BioUniTech.Lab SA Lausanne Scientific research and development
HemostOD SA Saint-Sulpice (VD) Manufacture of basic pharmaceutical products
Short Fusion Sàrl Carouge (GE) Arts creation and performing arts activities

A free account opens every company that looks like BioTissue SA, and what they have in common. Create a free account

Register publications

The commercial register publishes each notice only in the language of the registry office concerned, and Prospex reproduces it unchanged.

Address changed July 13, 2022

BioTissue SA, à Genève, CHE-110.088.936 (FOSC du 27.07.2021, p. 0/1005259023). Nouvelle adresse: Rue Paul-Bouchet 5, 1201 Genève.
Capital increased July 22, 2021

BioTissue SA, à Genève, CHE-110.088.936 (FOSC du 18.11.2020, p. 0/1005026094). Augmentation ordinaire du capital-actions porté de CHF 574'814 à CHF 2'130'414 par l'émission de 155'560'000 actions de CHF 0.01, nominatives, entièrement libérées par compensation de créances de CHF 1'555'600. Capital-actions: CHF 2'130'414, entièrement libéré, divisé en 2'130'414 actions de CHF 0.01, nominatives. Statuts modifiés le 01.07.2021.
Officers changed July 21, 2021

BioTissue SA, à Genève, CHE-110.088.936 (FOSC du 18.11.2020, p. 0/1005026094). Division des 16'700 actions de CHF 100 en 167'000'000 actions de CHF 0.01. Réduction du capital-actions porté de CHF 1'670'000 à CHF 574'814 par destruction de 109'518'600 actions de CHF 0.01, nominatives, pour supprimer un excédent de passif constaté au bilan. Capital-actions: CHF 574'814, entièrement libéré, divisé en 57'481'400 actions de CHF 0.01, nominatives. Statuts modifiés le 30.06.2021. Youssoufi Alaoui Hicham n'est plus administrateur; ses pouvoirs sont radiés. Nouvelle administratrice: Reincke-Schroeder Katrin, de et à Genève, avec signature collective à deux.
Capital increased Oct. 15, 2018

BioTissue SA, à Genève, CHE-110.088.936 (FOSC du 04.10.2018, p. 0/1004469888). Augmentation ordinaire du capital-actions porté de CHF 344'600 à CHF 1'670'000 par l'émission de 13'254 actions de CHF 100, nominatives, dont 13'248 actions entièrement libérées par compensation d'une créance pour CHF 1'324'800. Capital-actions: CHF 1'670'000, entièrement libéré, divisé en 16'700 actions de CHF 100, nominatives. Statuts modifiés le 03.10.2018. Youssoufi Alaoui Hicham est maintenant domicilié à Genève.

Source: Swiss Official Gazette of Commerce (FOSC).

¹ This information was estimated by machine learning and may contain errors.